Parker Institute For Cancer Immunotherapy

Date of Award

12.06.2018

Program

Prevent & Delay

Amount

$3,320,077.00

Term of Grant

48 months

Project Title

Understanding autoimmune diabetes following certain cancer immunotherapies.

Project Description

Funds to support studies to understand the pathogenesis of autoimmunity and diabetes associated with cancer immunotherapy which may (1) help prevent and manage it, and (2) begin discovering triggers, mechanisms, and/or biomarkers that may be generalizable to common forms of type 1 diabetes.